Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
24.31
+0.28 (1.17%)
At close: Jun 24, 2025, 4:00 PM
24.29
-0.02 (-0.08%)
After-hours: Jun 24, 2025, 7:59 PM EDT
Pfizer Revenue
Pfizer had revenue of $13.72B in the quarter ending March 29, 2025, a decrease of -7.82%. This brings the company's revenue in the last twelve months to $62.46B, up 11.65% year-over-year. In the year 2024, Pfizer had annual revenue of $63.63B with 6.84% growth.
Revenue (ttm)
$62.46B
Revenue Growth
+11.65%
P/S Ratio
2.21
Revenue / Employee
n/a
Employees
n/a
Market Cap
138.21B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 30, 2024 | 63.63B | 4.07B | 6.84% |
Dec 30, 2023 | 59.55B | -41.62B | -41.14% |
Dec 30, 2022 | 101.18B | 19.89B | 24.46% |
Dec 30, 2021 | 81.29B | 39.64B | 95.16% |
Dec 30, 2020 | 41.65B | 746.00M | 1.82% |
Dec 30, 2019 | Pro | Pro | Pro |
Dec 30, 2018 | Pro | Pro | Pro |
Dec 30, 2017 | Pro | Pro | Pro |
Dec 30, 2016 | Pro | Pro | Pro |
Dec 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
PFE News
- 13 hours ago - 10 'Safer' Dividend Buys Of Barron's Better Bets Than T-Bills For June - Seeking Alpha
- 3 days ago - The Dark Side Of Dividend Growth Investing - Seeking Alpha
- 4 days ago - I'm Buying Dividend Giants At Huge Discounts - Seeking Alpha
- 4 days ago - Will Pfizer Slash Its >7% Yielding Dividend? I Wouldn't Rule It Out - Seeking Alpha
- 4 days ago - Pfizer: An Offensive Play For A Bear Market - Seeking Alpha
- 6 days ago - RFK Jr weighs review of vaccines citing aluminum use, Bloomberg News reports - Reuters
- 6 days ago - RFK Jr.'s new vaccine advisors will vote on flu shots containing mercury - CNBC
- 6 days ago - Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga